SCHEMBL13201626

SCHEMBL13201626

CC(C)C(=O)CC(C)(C)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10308344 0.85 KDM4E (0.33)
SCHEMBL10212330 0.78 PIK3CD (0.30)
SCHEMBL10216230 0.76 MMP8 (0.32)
SCHEMBL10137806 0.76 CPT2 (0.48)
SCHEMBL11913942 0.76 ALDH1A1 (0.35)
SCHEMBL10212337 0.75 PIK3CD (0.31)
SCHEMBL826671 0.74 TDP1 (0.37)
SCHEMBL7910108 0.74 HMGCR (0.33)
SCHEMBL2189460 0.72
SCHEMBL2171159 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7767818-B2 Hepatitis C inhibitor dipeptide analogs BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-08-03 US disclosed
US-20090156822-A1 Hepatitis C Inhibitor Dipeptide Analogs BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-06-18 US disclosed
US-7511157-B2 racemic mixtures, stereoisomers or optical isomers, useful as protease inhibitors; viricides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-31 US disclosed